The US has banned the import of over 30 generic drugs manufactured by Ranbaxy.

Japanese drug manufacturer Daiichi Sankyo will pay Rs.737 per share to shareholders of Ranbaxy Laboratories in its Open Offer starting August 16.

Japanese drug maker Daiichi Sankyo has claimed that its open offer to acquire 92.5 million shares at Rs.5 each might change.

The generic versions of Astrazeneca's anti-ulcer drug, Prilosec 40 mg will be launched by Ranbaxy Laboratories Limited in the US.

Japan’s Daiichi Sankyo Company Ltd is going to acquire a majority stake in Ranbaxy Laboratories Ltd.